S

SYLENTIS

31 employees

SYLENTIS, biotech company focused on the development of new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Licensing
Glaucoma
Drug Discovey
Biotech
Research
siRNA RNAi Drugs
Production
Ophtalmology
Pharmaceuticals
R&D
Experimental drugs
RNAi
Biotecología
Bioinformatics
Rational Design
Ophthalmology
Dry eye syndrome
Gene Sinlencing
Target Therapies
RNAi Clinical Trials
eyes diseases

Date founded

2006

FAQ